Eagle Pharmaceuticals, inc. (EGRX)

[Bickema]

Is Eagle buying shares on the open market?

Who knows, I am impressed at how well this is holding 60, In the past Eagle has popped hard and faded hard on news. Feels different this time.

Upcoming catalysts
1. NDA for Ryanodex label expansion in Exertional Heatstroke (2H16)
2. ANDA Pemetrexed (2H16)
3. First Ever Eagle Pharmaceuticals Investor Day (specific date unannounced)
4. More clarity on Kangio pathway towards FDA approval


In regards to Pemetrxed, Eli Lilly will definitely take Eagle to court over patent infringements most notably their method of use patent, U.S. Patent No. 7,772,209, describes a method of administering pemetrexed disodium — Alimta's active ingredient — along with folic acid and vitamin B12 to reduce the drug’s side effects. This patent doesn't expire until 2022

Eagle claims to have a way around this.